Generics and biosimilar drugs are available at a substantially lower price for many drugs, but are often excluded from formularies by the very vendor we entrust to manage our costs.
DebugScreen: mobile
{
"author": {
"name": "George Huntley",
"webUrl": "/author/profile/george-huntley/",
"description": "",
"imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
"estimate": 4,
"social": [],
"articles": [
{
"uri": "/2023/07/07/employers-have-an-important-role-to-play-in-the-fight-against-obesity/",
"title": "Employers have an important role to play in the fight against obesity",
"byline": "George Huntley, CEO of the Diabetes Leadership Council",
"kicker": "",
"prettyDate": "July 07, 2023",
"timeToRead": "3 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/276/2023/07/Diabetes-Leadership-Council-July-2023-TL-Art.jpg",
"width": "616",
"height": "372"
},
"authors": [
{
"webUrl": "/author/profile/george-huntley-ceo-of-the-diabetes-leadership-council/",
"name": "George Huntley, CEO of the Diabetes Leadership Council"
}
],
"kickerNode": [],
"summary": "Almost half of working age Americans have obesity, creating health concerns for employees and employers alike.",
"body": null
},
{
"uri": "/2023/05/30/are-you-or-your-clients-running-a-health-plan-or-a-sick-plan/",
"title": "Are you or your clients running a health plan or a sick plan?",
"byline": "George Huntley, CEO of the Diabetes Leadership Council",
"kicker": "",
"prettyDate": "May 30, 2023",
"timeToRead": "4 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/276/2023/05/Diabetes-Leadership-Council-June-Article.jpg",
"width": "813",
"height": "490"
},
"authors": [
{
"webUrl": "/author/profile/george-huntley-ceo-of-the-diabetes-leadership-council/",
"name": "George Huntley, CEO of the Diabetes Leadership Council"
}
],
"kickerNode": [],
"summary": "With health care costs rising to more than $13,000 per employee, smart, preventive approaches to chronic conditions like diabetes help control costs.",
"body": null
},
{
"uri": "/2023/05/02/drug-rebates-under-scrutiny-how-prepared-is-your-health-plan/",
"title": "Drug rebates under scrutiny: how prepared is your health plan?",
"byline": "George Huntley, CEO of the Diabetes Leadership Council",
"kicker": "",
"prettyDate": "May 02, 2023",
"timeToRead": "4 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/276/2023/04/Diabetes-Leadership-Council-May-Art-1.jpg",
"width": "616",
"height": "372"
},
"authors": [
{
"webUrl": "/author/profile/george-huntley-ceo-of-the-diabetes-leadership-council/",
"name": "George Huntley, CEO of the Diabetes Leadership Council"
}
],
"kickerNode": [],
"summary": "With 10%-15% of health care costs spent on prescription drugs, it's important to understand the real cost impact of rebates.",
"body": null
},
{
"uri": "/2022/08/04/is-your-health-plan-covering-the-lowest-cost-drugs/",
"title": "Is your health plan covering the lowest-cost drugs?",
"byline": "George Huntley",
"kicker": "",
"prettyDate": "August 04, 2022",
"timeToRead": "5 minute",
"image": {
"uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2018/05/05PriceDrugs.jpg",
"width": "616",
"height": "372"
},
"authors": [
{
"webUrl": "/author/profile/george-huntley/",
"name": "George Huntley"
}
],
"kickerNode": [],
"summary": "Generics and biosimilar drugs are available at a substantially lower price for many drugs, but are often excluded from formularies by the very vendor we entrust to manage our costs.",
"body": null
}
]
}
}